GlassScriptPhysician profile
Mary Frances Daut
NPI 1366471211
$984.22
in general payments reported to CMS, 2019-2025
16 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $64.68 · 2021: $79.61 · 2022: $200 · 2023: $90.80 · 2024: $123 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $353.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $353.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $223.46 | 2019-2025 | Belbuca, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $165.23 | 2019-2024 | Relistor |
| Medtronic, INC. | $151.50 | 2021-2025 | Inceptiv, Synchromedii |
| Pfizer INC. | $119.59 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.05 | 2019 | |
| Shionogi INC | $44.84 | 2019 | |
| Zyla Life Sciences, INC. | $38.99 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $35.00 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.76 | 2025 | |
| Scilex Pharmaceuticals INC. | $22.06 | 2022 | |
| Amgen INC. | $21.25 | 2021 | |
| Abbott Laboratories | $19.12 | 2020 | |
| Abbvie INC. | $16.96 | 2021 | |
| Daiichi Sankyo INC. | $15.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.36 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Daut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.